Ledger.Open graph →
SEC Form D · filed January 14, 2019

Lantern Pharma

Offering
$535K
Sold
$535K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

David Silberstein · Dallas, TXDirectorArunkumar Asaithambi · Dallas, TXDirectorJohn Fucci · Dallas, TXDirectorPanna Sharma · Dallas, TXExec · DirectorMichael George · Pittsburgh, PADirectorTekin Mericli · Pittsburgh, PADirectorMike Stubler · Pittsburgh, PADirectorAlonzo Kelly · Pittsburgh, PAExec · DirectorDavid Keyser · Dallas, TXDirectorJames Brailean · SOLANA BEACH, CADirectorNick Braun · San Diego, CADirectorBen Zvaifler · San Diego, CADirectorAriel Zvaifler · San Diego, OHExec · DirectorDavid Keyser · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗